AHRQ Patient Safety Network

The Collection > Food and Drug Administration (FDA)

Narrow By

clear selections

Safety Target

•Device-related Complications (25)

•Diagnostic Errors (2)

•Medication Safety (58)

•Medical Complications (3)

•Nonsurgical Procedural Complications (4)

•Surgical Complications (4)

Origin/Sponsor
< All

Food and Drug Administration (FDA)

Resource Types

•Audiovisual (8)

•Book/Report (1)

•Journal Article (2)

•Legislation/Regulation (3)

•Meeting/Conference (2)

•Press Release/Announcement (45)

•Tools/Toolkit (4)

•Web Resource (15)

Error Types

•Epidemiology of Errors and Adverse Events (3)

•Active Errors (16)

•Latent Errors (12)

•Near Miss (1)

Approach to Improving Safety

•Quality Improvement Strategies (20)

•Legal and Policy Approaches (3)

•Error Reporting and Analysis (14)

•Communication Improvement (10)

•Human Factors Engineering (25)

•Technologic Approaches (6)

•Education and Training (17)

Clinical Areas

•Medicine (48)

•Nursing (2)

•Pharmacy (30)

Target Audience

•Health Care Providers (70)

•Health Care Executives and Administrators (40)

•Non-Health Care Professionals (16)

•Patients (32)

Setting of Care

•Hospitals (8)

•Ambulatory Care (10)

1 - 20 of 80

Show ExcerptDon't Show Excerpt

dropdown

PRESS RELEASE/ANNOUNCEMENT

Serious medication errors from intravenous administration of nimodipine oral capsules.

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; August 2, 2010.

PRESS RELEASE/ANNOUNCEMENT

Safety Investigation of CT Brain Perfusion Scans: Update 11/9/2010.

Rockville, MD: US Food and Drug Administration; November 9, 2010.

PRESS RELEASE/ANNOUNCEMENT

CT brain perfusion scans safety investigation: initial notification.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.

PRESS RELEASE/ANNOUNCEMENT

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 10, 2011.

PRESS RELEASE/ANNOUNCEMENT

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

FDA Alert [US Food and Drug Administration Web site]. March 19, 2009.

AUDIOVISUAL PRESENTATION

Preventing Medical Errors.

Food and Drug Administration (FDA) Patient Safety News. Show #79. September 2008.

PRESS RELEASE/ANNOUNCEMENT

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.

PRESS RELEASE/ANNOUNCEMENT

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; September 15, 2010.

PRESS RELEASE/ANNOUNCEMENT

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2009.

AUDIOVISUAL

Preventing fatal heparin overdoses.

Food and Drug Administration (FDA) Patient Safety News. Show #58. December 2006.

PRESS RELEASE/ANNOUNCEMENT

Transdermal drug patches with metallic backings.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; March 9, 2009.

PRESS RELEASE/ANNOUNCEMENT

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

FDA Public Health Advisory [US Food and Drug Administration Web site]. February 28, 2008.

PRESS RELEASE/ANNOUNCEMENT

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; May 23, 2012.

PRESS RELEASE/ANNOUNCEMENT

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; February 17, 2010.

PRESS RELEASE/ANNOUNCEMENT

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 6, 2007.

REGULATION

Safety Considerations for Product Design to Minimize Medication Errors: Draft Guidance.

Rockville, MD: Center for Drug Evaluation and Research, US Food and Drug Administration; December 2012.

REGULATION

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Draft Guidance.

Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; April 24, 2013.

MEETING/CONFERENCE PROCEEDINGS

Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors.

US Food and Drug Administration. June 24–25, 2010; Marriott Residence Inn, Bethesda, MD.

PRESS RELEASE/ANNOUNCEMENT

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

FDA Public Health Advisory [US Food and Drug Administration Web site]. March 11, 2008.

PRESS RELEASE/ANNOUNCEMENT

Kaletra (lopinavir/ritonavir) oral solution.

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2007.

1 2 3 4 5 Next >